Efficacy and Safety of Aficamten in Symptomatic Nonobstructive Hypertrophic Cardiomyopathy: Results From the REDWOOD-HCM Trial, Cohort 4

  1. MASRI, A.
  2. SHERRID, M.V.
  3. ABRAHAM, T.P.
  4. CHOUDHURY, L.
  5. GARCIA-PAVIA, P.
  6. KRAMER, C.M.
  7. BARRIALES-VILLA, R.
  8. OWENS, A.T.
  9. RADER, F.
  10. NAGUEH, S.F.
  11. OLIVOTTO, I.
  12. SABERI, S.A.R.A.
  13. TOWER-RADER, A.
  14. WONG, T.C.
  15. COATS, C.J.
  16. WATKINS, H.U.G.H.
  17. FIFER, M.A.
  18. SOLOMON, S.D.
  19. HEITNER, S.B.
  20. JACOBY, D.L.
  21. KUPFER, S.
  22. MALIK, F.I.
  23. MENG, L.I.S.A.
  24. SOHN, R.L.
  25. WOHLTMAN, A.M.Y.
  26. MARON, M.S.
  27. Mostrar todos os autores +
Revista:
Journal of Cardiac Failure

ISSN: 1532-8414,  1071-9164

Ano de publicación: 2024

Tipo: Artigo

DOI: 10.1016/J.CARDFAIL.2024.02.020 GOOGLE SCHOLAR lock_openAcceso aberto editor
Fonte de datos: Scopus